HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Antiperspirant OTC Labeling Flexibility Requested By CTFA

This article was originally published in The Rose Sheet

Executive Summary

Antiperspirant labeling should be allowed to drop the "Drug Facts" heading required for OTCs because it "is unnecessary and reduces the space available for important label information," the Cosmetic, Toiletry and Fragrance Association states in an April 11 citizen petition to FDA

You may also be interested in...



Antiperspirant Labeling Determined Appropriate In FDA Petition Denial

Modified labeling is not necessary for OTC antiperspirants because they can readily incorporate the information required under the final monograph in the "Drug Facts" format, FDA says in a letter to the Cosmetic, Toiletry and Fragrance Association

Antiperspirant Labeling Determined Appropriate In FDA Petition Denial

Modified labeling is not necessary for OTC antiperspirants because they can readily incorporate the information required under the final monograph in the "Drug Facts" format, FDA says in a letter to the Cosmetic, Toiletry and Fragrance Association

Cosmetic-Drug Products Subject To FDA's OTC Labeling Final Rule

FDA is not allowing an exemption for cosmetic-drugs in its final rule for standardized OTC drug labeling, announced by Vice President Gore at a March 11 ceremony. The reg is scheduled to be published in the Federal Register March 17.
UsernamePublicRestriction

Register

RS010211

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel